Previous studies have shown that during the progression of CIN to CC, TICs in TIME are gradually dominated by CD8+ T cells and macrophages, and the CD4/CD8 ratio is reversed, which implies a decrease in the body’s anti-tumor immunity (33). The gene discussed is CD4; the disease is neoplasm.